Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Imaging and Treatment Prediction for Metastatic Breast Cancer Using Gallium (68Ga) Tezatabep Matraxetan and Trastuzumab Deruxtecan

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Sweden
  • Monitoring the Effects of Epirubicin, Cyclophosphamide, and Docetaxel in Women with Breast Cancer

    Not yet recruiting

    3 1 1 1
    Sweden
  • Study of Azithromycin, Doxycycline, and Sodium Ascorbate for Patients with Early-Stage Breast Cancer

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Italy
  • Study of Atezolizumab, Pertuzumab, and Trastuzumab for Patients with HER2 Positive Early High-Risk and Locally Advanced Breast Cancer

    Not yet recruiting

    3 1 1 1
    Austria Belgium Germany Italy Romania Spain
  • Study on the Use of Iomeprol in Contrast Enhanced Mammography for Identifying Breast Cancer in Patients with BIRADS 4 or 5 Lesions

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Preventing Heart Failure in Early Breast Cancer Patients Receiving Anthracycline Therapy with Sacubitril and Valsartan (LCZ696)

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Norway
  • Study to evaluate gadopiclenol-enhanced magnetic resonance imaging for diagnosis in patients with breast cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Spain
  • Study of Pembrolizumab and Olaparib for Patients with Advanced HER2 Negative Breast Cancer and Specific Genetic Mutations

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Germany
  • Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

    Not recruiting

    3 1 1 1
    Austria Belgium France Germany Ireland Spain
  • Study on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Belgium France